コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 The objective of this study was to conjugate the previously described (1-N-(4-aminobenzyl)-3,6,10,13,
2 gnificant improvement in agonist activity of the previously described 2-aryloctahydrophenanthrene-2,3
12 hermore, our data also strongly suggest that the previously described accumulation of snR30 upon Rok1
15 phosphorylation sites on USF1 identified as the previously described activating site threonine 153 a
19 association (P < 4.2 x 10(-9)) but find that the previously described alleles do not explain more tha
22 Here, we examined the mechanism by which the previously described aminothieno pyridazine (ATPZ) s
24 human serum was also identified and included the previously described antigen TpF1 and the hypothetic
25 es hu5B3.v3 and MRCT10.v362 that, similar to the previously described AP33 and HCV1, bind to a highly
29 of an Ets domain-binding site, recognized by the previously described AST-1 Ets domain factor, and tw
30 TIP60 enzymatic activity described here and the previously described ATP-dependent positioning of H2
31 of three major conformations: in addition to the previously described ATP-hydrolyzing (ATPh) and ATP-
34 uloma, as demonstrated by the dissolution of the previously described B-cell-macrophage unit in granu
36 oving rAAV yield by 10-fold as compared with the previously described baculovirus/rAAV production sys
37 lity of the real-time PCR assay with that of the previously described beta-d-glucan (BDG) detection a
38 allosteric protein site that is unique from the previously described binding sites of other inhibito
40 free fraction when compared to compounds in the previously described biphenyl methylsulfone hydroxam
41 e produced BrlR being impaired in binding to the previously described BrlR-activated promoters of the
43 l region of the NP that did not overlap with the previously described C-terminal NP domain involved i
44 -subunit complex, and which is distinct from the previously described C-terminal winged-helix domain.
45 nt had compound heterozygote SCO2 mutations: the previously described c.1541G>A (p.E140K) mutation an
46 d and Epithelial morphologies clustered with the previously described C1-stromal, C5-mesenchymal and
47 acterization revealed an additional role for the previously described carbon-sulfur lyase SUR1 in pro
49 ed by the CD127 phenotype in comparison with the previously described CD4(+)CD25(hi) subpopulations,
50 enii ATCC 53582 and find that in addition to the previously described cellulose synthase operon, ATCC
56 indicate that Wor3 is highly integrated into the previously described circuit regulating white-opaque
57 switching, which represents a refinement to the previously described CL/K pathway, fine-tunes the pr
59 The model represents a simplification of the previously described coalescent with gene conversion
62 BQCA binding pocket partially overlaps with the previously described "common" allosteric site in the
63 muscular systolic mechanism that challenges the previously described concept of "isovolumic relaxati
67 ndent of PSB27, but was due to a mutation in the previously described cp26 gene that we found had no
70 gly, expression of CpuDGAT1 and CvFatB1 with the previously described CvLPAT2, a 10:0-CoA-specific Cu
71 = 12 and 17 nM, respectively), similarly to the previously described cyclic gamma-melanocyte-stimula
75 similar to macropinocytosis, albeit without the previously described dependence on oncogenic-Kras si
76 rovide a hyperpolarizing influence to offset the previously described depolarizing influence of the H
77 mer equilibrium in solution, and mutation of the previously described dimer interface within its caps
79 as telomeric to the 16p11.2 CNV and includes the previously described "distal" 16p11.2 microdeletion.
80 DNMT3A, therefore providing a mechanism for the previously described DNMT3L activation of DNMT3A.
81 lationship between Notch expressing HSCs and the previously described Domeless expressing progenitors
82 of the families with mutations conformed to the previously described DYT6 phenotype; however, age at
83 Complex1 (PRC1)-related complex, resembling the previously described E2F6-complex, and including G9A
84 ir characteristics and binding kinetics with the previously described E2P-ouabain complex to derive s
86 this observation, the ein2 mutation rescues the previously described effects of ethylene overproduct
87 ts on GnRH-I immunoreactivity in addition to the previously described effects of reproductive state.
88 is laminin-related function is essential for the previously described effects on axon growth promotio
90 raft components and reveal the mechanism of the previously described elevation of cAMP after cell de
91 jor replication, and mechanistically explain the previously described endosomal TLR-mediated resistan
93 a resolution of 1.92 A and the structure of the previously described ESA/Nps complex (2.42 A), it wa
94 e domain III at a point nearly equivalent to the previously described etr1-2 mutation in the other Ar
95 idence for three functional alleles of IRF5: the previously described exon 1B splice site variant, a
96 d found that these mice faithfully reproduce the previously described expression pattern of Frizzled1
97 near individualization complexes, similar to the previously described expression pattern of the caspa
98 atoconjunctival proliferation, as well as in the previously described familial pterygoid corneal dege
101 located approximately 3700 bp downstream to the previously described first exon found in hemopoietic
102 populations, or conformational sampling, of the previously described four conformations for HIV-1PR.
103 erest, five of these novel mutations, one of the previously described frequent variants (N221D), and
104 n the default mode network, closely matching the previously described frontotemporal pattern of chang
106 anemia compared to controls, consistent with the previously described function of CD47 in normal phag
110 lphabeta(+) gammadelta T cells differed from the previously described gammadelta T cell subsets in se
112 ckground of the female's mate contributes to the previously described gene expression changes, we ass
114 of MAPK phosphorylation that can account for the previously described genetic interaction between the
116 ctivation of nuclear GSK-3 that incorporates the previously described GSK-3 phosphorylation of LANA i
117 (IgA) protease gene, which is distinct from the previously described H. influenzae IgA protease.
121 so show that commendamide is responsible for the previously described hemolytic activity associated w
125 ound to site I and a pair of OBD subunits in the previously described hexameric spiral structure.
127 X4-suppressive factors differ from those of the previously described HIV R5-suppressive beta chemoki
130 III) cofactor to give two distinct products: the previously described homogeneous Mn(III)/Fe(III)-bet
131 re determined were found to belong to one of the previously described hospital-associated clonal clus
134 Megaviridae share some general features with the previously described icosahedral large DNA viruses,
135 contributions from a polymorphic gene(s) in the previously described Idd7 locus on the proximal port
137 ptional regulatory mechanism responsible for the previously described immunomodulatory characteristic
139 occurs from a promoter that is dissimilar to the previously described impC promoter but is still trig
141 phorylation of the ABD closely recapitulated the previously described in vivo phosphorylation pattern
142 hat a change from an IncA-positive strain to the previously described IncA-negative phenotype may inv
144 yesian Best Subset Regression (BBSR)] extend the previously described Inferelator framework, enabling
146 otent p53 inhibiting activity in addition to the previously described inhibitory effects of KSHV gene
149 ared with those with quiescent RA, including the previously described interleukin-6 (IL-6), oncostati
151 ng KCNA4, KCND2, and KCND3 genes, as well as the previously described J-wave-associated KCNJ8 gene, i
153 OPA formation during the first turnover, and the previously described kinetics for formation and deca
155 ide RD2, a rationally designed derivative of the previously described lead compound D3, which has bee
157 different regions of MSP3, we observed that the previously described leucine zipper region at the C
159 arameters, this reduction was prevented when the previously-described light procedure was applied.
161 tical kinase and leucine zipper domains with the previously described long isoform DLK-1L but acts to
162 ively high barriers for isomerization, while the previously described "long-bond" intermediate could
163 s 14 Da larger than its calculated mass with the previously described loss of the initiator methionin
166 e conclude that REAF is a major component of the previously described Lv2 restriction.IMPORTANCE Meas
167 FAT transcription factor, perfectly matching the previously described LXVP calcineurin-binding consen
168 uenza subtypes, such as H1; however, none of the previously described MAbs showed broadly neutralizin
169 reported promoter SNPs and one novel SNP in the previously described macrophage enhancer (ME.1).
171 uced an MDSC phenotype distinct from that of the previously described MDSC-inducing cytokine GM-CSF,
172 ignature encompasses all of the hallmarks of the previously described melanoma invasive signature.
173 compare the characteristics of the EIMS with the previously described membrane inlet mass spectrometr
174 nt hybrid syntheses which combine several of the previously described methods and other paths, such a
175 the amphipathic central helices observed in the previously described micelle-associated "hairpin" st
176 ue and critical function for MK signaling in the previously described MIF/CD74-induced survival pathw
178 y to what might be naively expected based on the previously described misfolding mechanism, we find t
179 on of structured RNA may account for some of the previously described molecular phenotypes (e.g., alt
180 therefore provide a structural rationale for the previously described monoexponential fluorescence de
181 mer or higher order oligomer, in contrast to the previously described monomer, in retinal rod outer s
182 ng properties of these novel proteins and of the previously described mouse SIGNs have been systemati
183 These phenotypes resemble those caused by the previously described mouse thymic virus (MTV), a put
185 ibitory effect on MRTF/SRF target genes than the previously described MRTF-A inhibitor CCG-203971.
186 e cytosol and the secretory pathway, whereas the previously described Msc2p-Zrg17p ER zinc importer c
189 zebrafish rescued the trabeculation but not the previously described myelination phenotype in the pe
190 notype associated with D453G, in common with the previously described N-terminal domain mutations Q31
193 -dependent signaling mechanism distinct from the previously described nephrin-Nck1/2 pathway necessar
194 glycemic levels and rCBF measurements within the previously described network of hypoglycemia-respons
197 pated constitutive transcription factors and the previously described NF-kappaB-responsiveness of the
199 ecause Gr/Nr-2 has no sequence homology with the previously described Nr (Never-ripe) ethylene recept
200 f estrogen receptor alpha (ERalpha) requires the previously described nuclear receptor coactivator pr
203 in a state, which is markedly distinct from the previously described nucleotide-free, inward-facing
204 ion, and catalytic activity were determined; the previously-described obesity risk SNPs N221D (rs6232
206 al axis variants was classified according to the previously described operative ABC classification.
207 al enzyme with both a hydrolase activity and the previously described (p)ppGpp synthetase activity, a
209 cessary for androgen synthesis is similar to the previously described pattern of proliferating neuron
210 ppocampal slice cultures from rat, either by the previously described PDZ ligand TAT-GESV or by the E
213 he cytoplasm subsequently, to participate in the previously described PIWI-interacting RNA (piRNA) pa
214 lation, we identified proteins that bound to the previously described point of termination for the ma
217 raction and provides a clear picture for how the previously described prolyl cis/trans isomerization
218 dynamic pattern formation including not only the previously described propagating waves, but also nea
219 re rigidly folded D-loop may explain some of the previously described properties of pY53-actin, inclu
223 ly two-lon2 and deg15, a mutant defective in the previously described PTS2-processing protease (DEG15
224 ssociated protein (MAP) 1B as the antigen of the previously described Purkinje cell cytoplasmic antib
228 mode of Akt regulation that is distinct from the previously described rapamycin-induced IRS-1 stabili
229 a major stereocilia membrane protein matches the previously described rapid turnover of proteins of t
230 TP1B by TrxR1 and is therefore distinct from the previously described reactivation of end-point oxidi
232 sphorylation by CDK5 is not mediated through the previously described regulation of PP1 activity by C
233 vectors that are significantly improved over the previously described replication-dependent vectors.
234 1 deletion mutants were used to reconstitute the previously described restriction phenotypes associat
236 factor 1 (DMRT1) gene that is independent of the previously described risk allele (rs755383) at this
237 he broader specificity of ELMOD2, as well as the previously described role for ELMO1 and ELMO2 in lin
242 pact of the Y169G substitution together with the previously described S170N, N174T "rigid loop" subst
245 AP form a binding site that is distinct from the previously described SAP-FcgammaRIIa binding site.
247 parameter optimization of a key aryl ring of the previously described SB1518 (pacritinib), the highly
248 ave mapped ascending and descending axons to the previously described scaffold of longitudinal fiber
250 f striking "probe dependence" indicates that the previously described selectivity of the modulator do
251 h, but up to 100 nm in length, that resemble the previously described self-assembled Abeta protofibri
252 pe I IFNs via a pathway that did not involve the previously described sensors TLR9, DAI, RNA polymera
256 Furthermore, SID-5 acts differently than the previously described SID-1, SID-2, and SID-3 protein
257 Finally, we show that sid-5 is required for the previously described sid-1-independent transport of
258 important role of multiphoton reactions and the previously described side reaction for dark state re
259 e expression profiling, and in particular of the previously described signatures of cell signaling pa
260 tic buffer medium (pH=4.6) was compared with the previously described silver nanoparticle-based (AgNP
261 uronal expression of Slack-A channels and of the previously described Slack isoform, now called Slack
262 ion of highly purified HSC, and enriches for the previously described Slamf1(lo)CD34(-) lymphoid-bala
263 shared circuitry between dsx and a subset of the previously described SP-responsive fru(+)/ppk(+)-exp
266 x and co-sediments in sucrose gradients with the previously described splicing factors Raa1 and Raa2.
267 e Src family inhibitor PP2, we observed that the previously described Src-dependent MT1-MMP phosphory
269 imates, this effect was strongly additive to the previously described stabilization of the prefusion
270 tionship of intra-axonal TC10 synthesis with the previously described stimulus-induced translation of
271 we find that MscL is not only necessary for the previously described streptomycin-induced potassium
272 psule (CB-StC) and discuss its relation with the previously described striatal capsule in vertebrates
274 ging was performed for (68)Ga-aquibeprin and the previously described, structurally related c(RGDfK)
277 identified E4orf4 binding domain lies above the previously described substrate binding site and does
280 at lacks amino acids 87 to 106, a portion of the previously described TBK1-binding domain of the gamm
281 tinct cis-elements in the promoter of let-7, the previously described temporal regulatory element (TR
282 the RAD50 gene and thus are contiguous with the previously described TH2 locus control region (LCR)
284 Loss-of-function mutations in components of the previously described thylakoid-localized Sec system,
285 by deletion of genes for both CafA and FimB, the previously described tip protein of the type 2 fimbr
286 The database is functionally expanded from the previously described Tomato Expression Database by i
287 esponse to iron and zinc, in accordance with the previously described transcriptional response of the
288 ansgenic mice more closely resemble LBs than the previously described transgenic mice (line M83) that
290 film formation at a stage similar to that of the previously described two-component system BfiSR.
291 Collectively, these ILEs share features with the previously described type III protein secretion syst
292 additional MVB sorting signals, we examined the previously described ubiquitination-independent MVB
296 Based on these results, the position of the previously described viral SRE (vSRE) within the HTL
297 irection of these genes relative to those of the previously described VSH-1 16.3-kb gene operon indic
298 striking was the fact that BGHBV, ACHBV, and the previously described white sucker hepadnavirus did n
299 able to determine that StmPr3 contributes to the previously described Xps-mediated rounding and detac
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。